Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) Other Non Operating Income (2016 - 2025)

Ocular Therapeutix (OCUL) has 12 years of Other Non Operating Income data on record, last reported at $1.7 million in Q4 2025.

  • For Q4 2025, Other Non Operating Income changed N/A year-over-year to $1.7 million; the TTM value through Dec 2025 reached $29000.0, up 100.1%, while the annual FY2025 figure was $29000.0, 100.1% up from the prior year.
  • Other Non Operating Income reached $1.7 million in Q4 2025 per OCUL's latest filing, up from -$938000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $62.2 million in Q3 2021 and bottomed at -$62.2 million in Q4 2021.
  • Average Other Non Operating Income over 5 years is -$2.3 million, with a median of -$86500.0 recorded in 2023.
  • Peak YoY movement for Other Non Operating Income: skyrocketed 1550.7% in 2021, then tumbled 2794900.0% in 2024.
  • A 5-year view of Other Non Operating Income shows it stood at -$62.2 million in 2021, then surged by 100.0% to $1000.0 in 2022, then crashed by 1419200.0% to -$14.2 million in 2023, then plummeted by 96.96% to -$28.0 million in 2024, then skyrocketed by 106.24% to $1.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were $1.7 million in Q4 2025, -$938000.0 in Q3 2025, and -$172000.0 in Q2 2025.